Monday , October 23 2017
Home / Letter From The Editor / Letter from the Editor, #797

Letter from the Editor, #797

DPP4-Inhibitors have been on the market for seven years and, in that time, over 1 million patients have used the drug. Out of those patients, 33 reported severe joint pain. Now the FDA has published a warning, which will possibly cause prescribers and patients to discontinue using the drug. Although calling attention to this may be important, one has to wonder — if we simply took a million random people, how many of them would have severe joint pain?

We are starting to see an increase in the use of genomic testing for medication selection and now there even seems to be a way to test genomes to see if a pre-diabetes patient will develop diabetes. Check out item 8 to see how it all works.

 

*****

Announcements:

dLifeTV.com: Sunday, September 6, 7PM ET

From dLife.com: “Minding your manners over diabetes — how to teach your friends and family boundaries that keep everyone happy. Then, Chef Michel Nischan serves up a diabetes-friendly Italian classic, and dLife visits “Hardball’s” Chris Matthews.” Sundays live online at dLifeTV.com at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at dLifeTV.com.

 

*****************************

We can make a difference!

*****************************

Dave Joffe, Editor-in-chief